Roche Holding AGRHHBF

One of the world’s largest pharmaceutical and diagnostics companies, the Swiss-based group develops and markets oncology, immunology, neuroscience, and rare disease treatments alongside a global diagnostics franchise. Its dual focus on patented biologic drugs and in vitro diagnostics positions it as a key player in precision medicine. Investors track its oncology pipeline, biosimilar exposure, and dividend stability as core drivers of long-term performance.